 Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > Gmp factory sale High Purity Tirzepatide peptide powder cas 2023788-19-2 with DMF

Gmp factory sale High Purity Tirzepatide peptide powder cas 2023788-19-2 with DMF buy - large image1

Gmp factory sale High Purity Tirzepatide peptide powder cas 2023788-19-2 with DMF buy - image1

Gmp factory sale High Purity Tirzepatide peptide powder cas 2023788-19-2 with DMF

Name: Gmp factory sale High Purity Tirzepatide peptide powder cas 2023788-19-2 with DMF
Brand: Bovita
SKU: pr2604102578
Price: 120 USD
Availability: InStock

TDS 2098 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

BEIJING

Brand:

Bovita

Packaging:

10g/aluminium foil bag

Price valid (until):

2026-05-10

Contact Supplier

 Chat Now

Bovitabiomed

Company Type:

Trader

Location:

China

Payment Terms:

TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average Lead Time:

10 days

Qualification:

Main Products:

Peptides Powder,Dietary Supplements Powder,APIs Active Pharmaceutical Ingredientsal ingredient,Pharmaceutical Intermediates,Food Additives,Pharmaceuticals Machinery

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Tirzepatide Powder (CAS 2023788-19-2)

Product Name: Tirzepatide Powder

CAS Number: 2023788-19-2

Molecular Formula: C₂₄₅H₃₆₉N₆₅O₆₈

Molecular Weight: 4753.6 g·mol⁻¹

Class: GLP‑1R / GIPR dual agonist peptide

1. Product Description

Tirzepatide is a long‑acting dual agonist of glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) receptors. It is a synthetic linear peptide with a fatty acid side chain that binds strongly to albumin, significantly extending its half‑life and enabling sustained metabolic effects.

Our Tirzepatide Powder is supplied as a white to off‑white lyophilized powder with high purity, excellent stability, and consistent batch‑to‑batch performance under strict quality control.

2. Key Specifications

Item	Specification
Assay (HPLC)	≥98.0%
Appearance	White to off‑white lyophilized powder
Water Content	≤5.0%
Total Impurities	≤2.0%
Single Unknown Impurity	≤0.5%
Peptide Purity	≥98.0%
Bacterial Endotoxins	≤5 EU/mg
pH	5.0 – 7.0 (solution)

3. Mechanism of Action

Simultaneously activates GLP‑1 and GIP receptors to synergistically improve glycemic control and weight reduction.
Enhances glucose‑dependent insulin secretion and suppresses glucagon release.
Delays gastric emptying, reduces appetite, and promotes significant body weight loss.
Improves lipid profiles and metabolic markers in patients with type 2 diabetes and obesity.
Long half‑life supports once‑weekly dosing in finished pharmaceutical formulations.

4. Main Applications

Pharmaceutical API: For the development and manufacture of injectable products for type 2 diabetes mellitus and chronic weight management.
R&D Use: Preclinical pharmacology, toxicology, formulation optimization, and biomedical research.
Scientific Research: Used in studies of metabolism, obesity, diabetes, and related cardiometabolic disorders.

5. Our Advantages

High Purity: ≥98.0% by HPLC, low impurity profile, ideal for R&D and formulation development.
Stable Quality: Strict production control and full analytical data including COA, HPLC, MS, NMR.
Professional Peptide Manufacturing: Produced in GMP‑compliant cleanroom facilities with strict contamination control.
Cold‑Chain Stability: Specialized packaging to maintain peptide integrity during storage and shipping.
Complete Documentation: Full technical dossiers available upon request.

6. Storage & Handling

Storage: Store at ≤ -20°C, keep away from light, heat, and moisture.
Transport using ice packs or dry ice to preserve stability.
Shelf Life: 2 years when stored properly.
Avoid repeated freeze‑thaw cycles.
Wear protective gear; avoid inhalation, skin and eye contact.

7. Safety & Compliance Notice

For research and industrial manufacturing use only.
Not for direct human or animal consumption.
Comply with all local regulations for peptide APIs, pharmaceutical raw materials, and controlled substances.
Full MSDS and safety data provided with every order.

8. Packaging & Shipping

Packing: 1g, 5g, 10g, 50g, 100g, 1kg sealed vials / aluminum foil bags; customizable.
MOQ: Flexible, supports small R&D orders.
Lead Time: In-stock orders shipped within 2–3 working days.
Shipping: Cold chain via DHL, FedEx, UPS, air or sea freight.

ECHEMI Editorial Reference

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

Certificates

Basic Info

Product Name:

Tirzepatide

Other Name:

LY3298176;

CAS No.:

2023788-19-2

Molecular Formula:

C225H348N48O68

Molecular Weight:

4813

EC Number:

200-001-8

Categories:

Polypeptide

Characteristics

Appearance:

White to off-white

Research

Class:

Dual agonist — GIPR, GLP-1R

Status:

FDA-approved (Mounjaro / Zepbound)

Mechanism:

Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

EC50 (Human GLP1R):

0.934 nM

EC50 (Human GIPR):

0.0224 nM

Source:

Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

Clinical Development:

NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

FDA:

Mounjaro, Zepbound (approved 2022-05-13)

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Disclaimer:

Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

See More Tirzepatide Properties 

Seller Information

Business Type:
Trader

Main Products:
Peptides Powder,Dietary Supplements Powder,APIs Active Pharmaceutical Ingredientsal ingredient,Pharmaceutical Intermediates,Food Additives,Pharmaceuticals Machinery

Location:
Room 403 No.62 of Shan Shui Huihao Gardan, Dou Dian Town,Fangshan District, Beijing,China

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
10 days

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2026

Bovita is a forward-thinking biotech startup specializing in high-purity peptide products and premium dietary supplement raw materials. Rooted in the rigorous standards of China’s pharmaceutical and chemical industry, we are dedicated to bridging scientific excellence with global wellness demands, with a core focus on serving the North American and European markets.

Company Profile

Inquiry History

2098 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	2023788-19-2 in unlabeled vials 10, 15 and 30 mg	10	Feb 14, 2024
United States	Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries	10 MG	Apr 3, 2024
United States	Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides	2 MT	Dec 13, 2025
Brazil	2023788-19-2	20 PCS	Sep 12, 2026
Hongkong, China	2023788-19-2	1 KG	Aug 13, 2026
Germany	2023788-19-2	1 MG	Jun 18, 2026
United States	2023788-19-2 Retatrutide	1 G	Sep 22, 2023
United States	Tirzepatide 2023788-19-2	2	Feb 19, 2024
United States	Tirzepatide 2023788-19-2	10 G	Oct 31, 2023
United States	2023788-19-2 Trizepatide	10 MT	Oct 29, 2023
United States	Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder	1	Dec 2, 2025
United States	Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss	2 KG	Oct 20, 2023
United States	Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2	1 MT	Jan 25, 2024
United States	Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide	1 MT	Oct 20, 2023
United States	supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder	10 MG	Apr 4, 2024
Kenya	Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2	30 MG	Dec 26, 2025
United States	Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide	10	Dec 30, 2024
United Kingdom	Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire	100 G	Nov 4, 2023
Canada	99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2	2 MT	Oct 22, 2023
United Kingdom	tirzepatide	10 MG	Oct 21, 2025

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Export Oriented Tirzepatide Raw Peptide COA MSDS Provided Fast Worldwide Logistics	Pharmaceutical Grade/99	$22/UNIT FOB	HONG KONG BURSON POLYPEPTIDE R&D LIMITED	Inquiry
Tirzepatide high purity 99% 5mg 10mg 15mg 20mg 30mg 50mg 60mg US warehouse	Pharmaceutical Grade/99	$1/UNIT FOB	Hubei Meisang Trading Co.,Ltd	Inquiry
Fast Delivery Tirzepatide Premium quality99.%+purity CAS2023788-19-2 Manufacturer wholesale lyophilized powder peptide in stock	Pharmaceutical Grade/99	$1/UNIT FOB	Hangzhou Zhongma Trading Co., Ltd.	Inquiry
Tirzepatide purity Reta 99% purity Retatrutide CAS 2381089-83-2 weight loss peptides China Factory	Pharmaceutical Grade/99	$44/UNIT FOB	Hangzhou Zhongma Peptide	Inquiry
Tirzepatide 60mg Research Peptide, Powder Form, Laboratory Research Product, 60mg Vial	Research Grade/99	$50/UNIT FOB	PGpeptides	Inquiry